How Biovail May Foil The ShortsBy
Money manager Stanley Goldring thinks he has found another Amgen or Conseco--stocks that have been bonanzas for him. Goldring, who heads the KG Securities unit at investment bank Ladenburg Thalmann, is focusing on Biovail (BVF), which the short-sellers love to hate. Now at 24 a share, Biovail reached 38 3/4 in late May--before the shorts pummeled it.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.